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Edited by Varda RotterAbstract In p53-dependent apoptosis in response to genotoxic
and hypoxic stress, a fraction of induced wild-type p53 rapidly
translocates to mitochondria, triggering a rapid ﬁrst wave of
mitochondrial membrane permeabilization and apoptosis that is
later fortiﬁed by the transcriptional program of p53. However,
whether this direct mitochondrial program also occurs upon
oncogenic stress is unknown. In normal cells, oncogenic signals
can induce a p53-dependent fail-safe mechanism to counter
uncontrolled proliferation by engaging p53-dependent apoptosis.
To address whether mitochondrial p53 contributes to oncogene-
induced fail-safe apoptosis, p53 translocation was determined
in primary human epithelial and endothelial cells overexpressing
c-Myc, E1A or E2F1. Serum starvation of these cells, but not of
control cells, triggered rapid p53 accumulation at mitochondria,
accompanied by cytochrome c and SMAC release and followed
by apoptosis. Our data establishes the contribution of the tran-
scription-independent mitochondrial p53 pathway to apoptosis
of primary cells in response to deregulated oncogenes.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Deregulated oncogenes activate p53 through a signaling
pathway involving the retinoblastoma protein and the tumor
suppressor p19ARF and, dependent on the cellular context,
cause p53-dependent apoptosis or senescence [1–3]. Speciﬁ-
cally, activated oncoproteins induce ARF expression [4–9]
and thereby activate p53 through inhibition of the E3 ubiquitin
ligase Mdm2. It has been shown that the E1A, c-Myc and
E2F1 oncoproteins can trigger a p53-dependent apoptotic re-
sponse in non-immortal primary cells [1,3,10–16]. With respect
to the p53-speciﬁc mechanisms of oncogene-induced apoptosis,
only p53-dependent modulation of target gene transcription
have so far been described. For example, c-Myc-activated
p53 triggers induction of the p53 target Puma in MEFs [17].
Conversely, c-Myc suppresses the p53-mediated induction of
the cdk-inhibitor p21(Cip1) by directly recruiting the DNA-
binding protein Miz-1 to the p21 promoter. This blocks p53-
mediated p21 induction and cell cycle arrest and instead favors
induction of apoptotic target genes [18,19].*Corresponding author. Fax: +1 631 444 3424.
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doi:10.1016/j.febslet.2005.09.074It has recently become clear that non-transcriptional cyto-
plasmic functions of p53 make a signiﬁcant contribution to
the overall p53-mediated apoptotic program. Early in the
course of p53-dependent apoptosis, caused by such distinct
stress inducers as DNA-damaging drugs, c-irradiation, hypox-
ia or exposure to oxidative stress, a fraction of wild-type p53
protein rapidly undergoes translocation to mitochondria [20–
32]. Mitochondrial p53 directly induces oligomerization of
the eﬀector protein Bak, leading to outer mitochondrial mem-
brane permeabilization (OMMP) with release of apoptotic
activator proteins [22,33]. Moreover, puriﬁed p53 protein in-
duces oligomerization of Bak and permeabilization of the out-
er mitochondrial membrane, and strongly promotes
cytochrome c release from healthy unstressed mitochondria.
One mechanism by which p53 achieves OMMP is by forming
complexes with the anti-apoptotic BclXL and Bcl2 proteins to
block their function [22]. In support of this notion, deliberate
targeting of wild-type p53 to mitochondria is suﬃcient to
launch apoptosis directly from this organellar platform in
p53 null cells [22]. Tumor-derived missense mutants of p53
in the DNA binding domain concomitantly fail to bind to
BclXL and to induce OMMP [22]. However, it is currently un-
known whether this direct mitochondrial program also occurs
upon oncogenic stress, the last category of potent and physio-
logically highly relevant stress that has not been tested in this
context. Here, we show that in primary human cells of diﬀerent
lineages, p53 indeed translocates to mitochondria early in the
course of apoptosis in response to deregulated expression of
clinically relevant mitogenic oncogenes. The transcription-
independent mitochondrial p53 pathway might therefore con-
tribute to the apoptotic response that occurs in the presence of
oncogenic signaling.2. Materials and methods
2.1. Cells lines
Primary human mammary epithelial cells (HMEC; Cambrex Bio
Science Rockland, Inc.) and human umbilical vein endothelial cells
(HUVEC; Cascade Biologicals), both passage 3, were grown in media
recommended by the manufacturer.
2.2. Retroviral constructs and infection
We used replication-defective MSCV-based retroviral vectors
expressing either E1A, c-Myc or E2F1 or empty control vector as well
as a GFP-expressing retrovirus, as previously described [34–36].
Amphotropic Phoenix A packaging cells were co-transfected with a
mixture of oncogene-expressing and GFP-expressing retroviral vectors
at a ratio of 10:1 to produce retroviral stocks. For retroviral infections,
cells grown to 80% conﬂuence on 150 mm diameter dishes wereblished by Elsevier B.V. All rights reserved.
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retroviral stock. This process was repeated four times, each time allow-
ing the cells to recover for 6 h in medium after infection. After the last
infection, cells were monitored for GFP expression by microscope. Vis-
ible green ﬂuorescence of about 10% of cells indicated that nearly all
cells were infected, as veriﬁed by FACS analysis against parental cells.
Cells were analyzed by Western blotting to verify oncogene expression
2–3 days after the last infection. After 4.5 h of serum withdrawal, cells
were harvested at the ﬁrst signs of early apoptosis (i.e. a few cellsFig. 1. Oncogenic signals engage the transcription-independent mitochond
retroviral vectors driving expression of E1A, c-Myc, E2F1 or empty vector
starved for 4.5 h. (A) Whole cell lysates were prepared and mitochondria
immunoblotted with the anti-human p53 antibody DO-1. Oncogene expressio
purity of mitochondrial fractions was assessed by immunoblotting for the nu
with the mitochondrial markers COX IV and mthsp70. (B) The amount of ap
trypan blue positive cells. (C) Flow cytometric analysis of HUVEC cells a
starvation. The percentage of apoptotic cells is represented by the sub-G1 frstarted to ﬂoat) and immediately processed for mitochondrial puriﬁca-
tion as described [25]. In parallel, aliquots were also processed for eval-
uation of cell viability by trypan blue exclusion and apoptosis by
FACS analysis of DNA content.2.3. Western blotting
Proteins from whole cell or puriﬁed mitochondrial lysates (5–10 lg
of protein) were separated on SDS–polyacrylamide gels and trans-rial pathway of p53 in primary HUVEC cells. After infection with
for 2–3 days, primary human endothelial HUVEC cells were serum
puriﬁed. Equal amounts (5 lg per lane) of total protein from were
n was veriﬁed using antibodies speciﬁc for E1A, c-Myc and E2F1. The
clear marker protein PCNA. Mitochondrial enrichment was monitored
optotic cells after 4.5 h of serum starvation, measured as percentage of
fter E1A or empty vector expression, with or without 4.5 h of serum
action.
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Schuell). Membranes were incubated with antibodies speciﬁc for
p53 (DO1), E2F1 (KH-95), E1A (13S-5) and c-Myc (N-262) (all from
Santa Cruz Biotechnology). Blots were reprobed for PCNA (PC-10,
Santa Cruz) to verify lack of nuclear contamination as well as for
COX IV subunit 4 (Clone 1A12, Molecular Probes) and mthsp70
(Clone JG1, Aﬃnity Bioreagents) to verify equal mitochondrial load-
ing. To detect mitochondrial eﬀector proteins, Smac/Diablo (RD Sys-
tems) and cytochrome c (Clone 7H8.2C12, BD PharMingen)
antibodies were used.
2.4. FACS analysis
For cell cycle analysis, cells were ﬁxed in 70% ethanol, stained with
propidium iodide (Sigma) and analyzed using FACS Calibur (Becton-
Dickinson) and ModFit LT software (Verity Inc.).Fig. 2. Oncogenic signals engage the transcription-independent mito-
chondrial pathway of p53 in primary HMEC cells. Primary human
mammary epithelial HMEC cells were serum starved for 4.5 h after
infection with retroviral vectors overexpressing either E1A, c-Myc or
E2F1 or empty vector for 2–3 days. Control cells were treated with
adriamycin for 4 h. Equal amounts (5 lg per lane) of total protein
from whole cells and mitochondrial lysates were immunoblotted with
the anti-human p53 antibody DO-1. Oncogene expression was veriﬁed
using antibodies against E1A, c-Myc and E2F1. The purity of
mitochondrial fractions was assessed by immunoblotting for the
nuclear marker protein PCNA. Mitochondrial enrichment was mon-
itored with the mitochondrial markers COX IV and mthsp70.3. Results
We and others have demonstrated that a fraction of stress-
induced wild-type p53 protein rapidly translocates to mito-
chondria in response to genotoxic, hypoxic and oxidative stress
in multiple cellular systems in culture and in vivo in mice [20–
32]. Moreover, p53 that is deliberately targeted to mitochon-
dria and devoid of any transactivation function is suﬃcient
to launch apoptotic cell death directly from the mitochondrial
platform in p53-null tumor cells in culture and in mice [22]
(Talos et al., 2005 in press). To address whether oncogenic sig-
nals are also able to engage the transcription-independent
mitochondrial pathway of p53, we analyzed early passage pri-
mary human endothelial and epithelial cells transduced with
retroviral vectors overexpressing either E1A, c-Myc or E2F1
or empty vector.
Of note, in contrast to transfection and adenoviral infec-
tion, retrovirally driven expression generates only mild to
moderate expression levels, thereby better approaching those
pathologic concentrations of deregulated oncogenes present
in tumors. This is particularly true for retrovirally-driven c-
Myc levels that were only minimally elevated compared to
endogenous levels (Figs. 1A and 2, left bottom panel). As
previously described, ectopic E1A expression in HUVEC cells
induced E2F1 levels [37]. We ﬁrst analyzed the subcellular
distribution of p53 in primary endothelial HUVEC cells over-
expressing E1A, c-Myc or E2F1 early during apoptosis in-
duced by serum starvation. To this end, mitochondria were
puriﬁed by sucrose gradient centrifugation. Mitochondrial
preparations were essentially free of the nuclear contamina-
tion marker PCNA, but enriched in the mitochondrial mark-
ers mthsp70 and cytochrome oxidase IV (Fig. 1A). After
expression of E1A, E2F1 or c-Myc for 2–3 days, total cellular
p53 levels were moderately induced compared to control cells
infected with empty virus, although the cells appeared com-
pletely healthy. Importantly however, after 4.5 h of serum
starvation, HUVEC cells overexpressing E1A, E2F1 or c-
Myc, but not cells transduced with empty virus (vector),
exhibited a signiﬁcant amount of p53 accumulation at the
mitochondria (Fig. 1A, top right panel). Concurrent with
p53 translocation, mitochondria from oncogene-expressing
but not from control cells released apoptotic activators from
the intermembranous space, including cytochrome c and
Smac (bottom right panel). Concomitantly at 4.5 h after ser-
um starvation, 25–33% of oncogene-expressing HUVEC cells
were trypan blue positive, depending on the oncogene, and
cells started to detach from the culture dish. This constituteda signiﬁcant increase over background (empty virus)
(Fig. 1B). Likewise, at that time point, 15% of E1A express-
ing cells sorted to the sub-G1 fraction (Fig. 1C). Within 24 h
apoptosis was complete with virtually 100% dead ﬂoating
cells.
To test the generality of this response, we analyzed low pas-
sage primary human mammary epithelial cells (HMEC).
HMEC derive from the ectodermal lineage, in contrast to cells
derived from the mesodermal lineage represented by the endo-
thelial HUVEC. As seen with HUVEC cells, serum withdrawal
triggered apoptosis in HMEC cells overexpressing c-Myc, E1A
or E2F1 but not in vector control cells (data not shown). The
kinetics of apoptosis was identical to HUVEC, with the ﬁrst
cells starting to detach from the dish at 4.5 h after serum with-
drawal. And as seen with HUVEC, HMEC cells also had
undergone signiﬁcant p53 accumulation at mitochondria at
that time point (Fig. 2). Thus, oncogene-induced mitochon-
drial p53 translocation during early apoptosis appears to be
a general response.4. Discussion
Our data indicate that the early phase of the apoptotic fail-
safe response to deregulated mitogenic oncogenes engages the
transcription-independent mitochondrial pathway of p53. This
occurs in primary human cells of variable ontogenic origin.
Until now, p53-dependent apoptosis in response to oncogene
deregulation has been entirely attributed to its transcription-
dependent pathways. We demonstrate here for the ﬁrst time
that the transcription-independent mitochondrial p53 pathway
6082 A. Nemajerova et al. / FEBS Letters 579 (2005) 6079–6083contributes to the total p53-dependent apoptotic response to
oncogenic signaling.
We chose E2F1 and c-Myc because of their central physio-
logical relevance for human and rodent tumor development
and tumor maintenance [38,39]. The viral E1A oncoprotein
indirectly also deregulates E2F transcription factors by bind-
ing and sequestering the Rb protein, thereby releasing free
E2F factors [37]. We chose human epithelial cells of non-ﬁbro-
blastic lineages because >90% of human tumors are of epithe-
lial origin. We chose primary cells because activated oncogenes
were shown to induce a p53-orchestrated fail-safe program in
these cells that culminates in their elimination via apoptosis
[40]. Our ﬁndings are in complete agreement with a simulta-
neous study that showed that during the early phase of aden-
oviral infection, when E1A induces cellular p53, a fraction of
p53 is targeted to mitochondria [41]. In virus-infected cells, a
large fraction of the anti-apoptotic viral protein E1B-19K, a
homolog of Bcl2/XL, is also localized at mitochondria. In
analogy to our earlier ﬁndings with BclXL, E1B-19K forms
an inhibitory complex with p53. Moreover, p53 mutations
within the DNA-binding domain also reduce the interaction
with E1B-19K [22,41]. This suggests that mitochondrial
p53-induced apoptosis may contribute to eﬃcient cell lysis
and viral spread but that E1B-19K may regulate this apoptotic
activity.
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